Generics 174

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Drotaverine manufacturers

174 products found

Filters

174 products found

drotaverine

Tablets 40 mg, 80 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Saudi Arabia , Vietnam , United Arab Emirates
Manufacturer #1765
A pharmaceutical manufacturer based in the EU that is active in 10+ countries selling its products in Europe, CIS, Asia, and the East for 20+ years. The production facilities are cGMP compliant. The main dosage forms are solid dosage forms. The company provides documentation in CTD/eCTD format and stability studies. The company has several branches in Europe.

Manufacturer usually replies in 6 days

drotaverine

Tablets 40 mg, 80 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Available for
Licensing with supply
Manufacturer #15924
A global pharmaceutical leader who specializes in affordable drug delivery and at the same time patient care services. The market leader that not only manufactures but also provides pharmaceutical care at different corners of the globe.

Manufacturer usually replies in 9 days

drotaverine

Tablets, film coated 80mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Vietnam
Manufacturer #11542
It is one of the most rapidly expanding pharmaceutical enterprises in Europe. A cutting-edge pharmaceutical manufacturing plant and a laboratory with the highest-quality equipment are among the manufacturing facilities. The production lines and laboratories follow European standards, and a team of competent personnel ensures that these guidelines are followed. The manufacturing procedures meet all GMP regulations, whereas clinical trial goods are made per GLP and GMP principles.

Manufacturer usually replies in 9 days

drotaverine

Tablets 40 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #1178
A pharmaceutical manufacturer based in the EU that has been selling its products in Europe and CIS for 20+ years. Key production lines are Rx, nutraceuticals, and dermo-cosmetics. The company's production lines are GMP-compliant. Main dosage forms include solid oral, suppositories, creams, and gels.

Manufacturer usually replies in 6 days

drotaverine

Tablets 40 mg, 80 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Vietnam
Registered in
Bulgaria
Available for
Licensing with supply, Distribution only
Manufacturer #456
A GMP-approved pharmaceutical manufacturer with 25+ years of experience based in Europe. Available for manufacturing, licensing, transfer, and regulatory activities. The company’s portfolio consists of different types of production: tablets, capsules, oral liquids, injections, powders, and ointments. Product lines are not only in medicine with and without prescription, but also, in nutritional supplements. Products are available in Europe, Africa, West, and South Asia. Furthermore, the company handles API/materials sourcing, regulatory support, supplier qualification, and others.

Manufacturer usually replies in 13 days

drotaverine

Ampoules, injection 40 mg/2 ml , 20 mg/1 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Vietnam
Registered in
Bulgaria
Available for
Licensing with supply, Distribution only
Manufacturer #456
A GMP-approved pharmaceutical manufacturer with 25+ years of experience based in Europe. Available for manufacturing, licensing, transfer, and regulatory activities. The company’s portfolio consists of different types of production: tablets, capsules, oral liquids, injections, powders, and ointments. Product lines are not only in medicine with and without prescription, but also, in nutritional supplements. Products are available in Europe, Africa, West, and South Asia. Furthermore, the company handles API/materials sourcing, regulatory support, supplier qualification, and others.

Manufacturer usually replies in 13 days

drotaverine

Solution for injection 20 mg/ml - 2 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Registered in
Bulgaria , Kazakhstan , Tajikistan , Turkmenistan , Uzbekistan
Available for
Licensing with supply
Manufacturer #15813
A pharmaceutically oriented holding company that provides pharmacological solutions like never before. Their core business line entails dealing with the development, manufacturing, and distribution of pharmaceutical products, food supplements as well as cosmetics too.

Manufacturer usually replies in 12 days

drotaverine

Tablets 40mg, 80mg

Dossier type
EU CTD
Dossier status
Under development
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #10033
A pharmaceutical manufacturer based in Europe specializes in development and manufacturing for 10+ years. Key production lines are Rx, OTC, and nutraceuticals. The main therapy areas include the immune system, CNS, and cardiovascular system. The main dosage forms include solid oral and injectable.

Manufacturer usually replies in 11 days

drotaverine + metamizole + caffeine

Tablets 40 mg + 400 mg + 60 mg, 80 mg + 400 mg + 60 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Vietnam
Comments
OTC
Manufacturer #358
A pharmaceutical manufacturer based in the EU that is active in 70+ countries worldwide selling its products in the EU, Australia, Pacific region, and Asia for 30+ years. The company owns several manufacturing plants that comply with EU GMP requirements with production facilities for Rx products, OTC products, nutraceuticals, and medical devices. Its key therapy areas are diabetology, oncology, and neuropsychiatry. The company possesses several R&D centers with hundreds of patents and provides e-CTD format dossiers.

Manufacturer usually replies in 23 days

drotaverine

Tablets 80 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Comments
OTC
Manufacturer #279

Manufacturer usually replies in nan days

drotaverine

Suppositories 40 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Moldova
GMP approvals
EU GMP
Manufacturer #21077

Manufacturer usually replies in 3 days

drotaverine

Tablets, film coated 80 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO, India
Registered in
India
Available for
Licensing with supply, Distribution only
Manufacturer #22627

Manufacturer usually replies in 4 days

drotaverine + mefenamic acid

Tablets 80 mg+250 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
FDA
Manufacturer #18850

Manufacturer usually replies in 2 days

drotaverine

Ampoules, injection 20 mg/ml - 2 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Available for
Licensing with supply, Distribution only
Manufacturer #18885

Manufacturer usually replies in 7 days

drotaverine

Tablets 80 mg, 40 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Pakistan
GMP approvals
Sri Lanka, Afghanistan, Vietnam, Cambodia, Myanmar
Manufacturer #21102

Manufacturer usually replies in 5 days

drotaverine + mefenamic acid

Tablets 80 mg + 250 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20428

Manufacturer usually replies in 4 days

drotaverine

Injection 40 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20360

Manufacturer usually replies in 1 days

drotaverine + mefenamic acid

Tablets 80 mg + 250 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20360

Manufacturer usually replies in 1 days

drotaverine

Injection 40 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19861

Manufacturer usually replies in 3 days

drotaverine + mefenamic acid

Tablets for oral solution 80 mg + 250 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19861

Manufacturer usually replies in 3 days

Want to view all 174 products? Create your free account today!

Drotaverine:

Drotaverine, also known by its INN name of drotaverin, is a medication belonging to the antispasmodic family of drugs. It is structurally related to papaverine and is used to increase cervical dilation during childbirth as well as in the treatment of functional bowel disorders and alleviating pain in renal colic. Although widespread regulatory approval is generally lacking due to drug effectiveness and safety concerns, with many clinical trials continually ongoing. It can be found on drotaverine manufacturers and drotaverine suppliers pharmaceutical products list, where it is frequently listed for sale and wholesale by distributors on the global marketplace at a variety of cost and price points. Some notable company brand names that are produced by manufacturers include Drotin, No-Spa, and Taverin.

Method of action of drotaverine:

Drotaverine belongs to a group of drugs and medications termed antispasmodic. This refers to pharmaceutical products or other agents that are capable of suppressing muscle spasms. To this effect, drotaverine has no anticholinergic effects but functions as a selective inhibitor of phosphodiesterase 4. This serves to inhibit the phosphodiesterase mediated hydrolysis of cAMP, increasing cAMP concentration, while decreasing Ca uptake to the cell and changing the distribution of calcium. Additionally, it may also exhibit minor allosteric calcium channel blocking properties, further contributing to its function.

Form and dosage of drotaverine:

As with all drugs, the final form and packaging of drotaverine is dependent on the manufacturers and suppliers, as well as the specific distributors and order. However, typically it is available for sale in different forms such as ampoules, tablets, solution for injection, tablets, film-coated tablets, and vials. In most jurisdictions a prescription is required to obtain drotaverine, as such, the accompanying advice of the medical professional on dosing should be followed as it is highly dependent on the specific underlying ailment. A typical regiment, as described by manufacturers and literature, in the treatment of renal colic pain is 40-80 mg taken 3 times a day for adults.

Drotaverine on Pipelinepharma:

Currently, at the time of writing, we have found 22 verified drotaverine manufacturers and drotaverine suppliers from our online global list of B2B sellers. These manufacturers, suppliers, and distributors have drotaverine available for wholesale B2B order and are located in various countries including the European Union and the United States. Each seller listed on our online company marketplace has been verified by the Pipelinepharma team according to strict quality control. This ensures the seriousness of the provider, facilitating buyer ease and reducing sourcing mileage.

Price of drotaverine and how to buy:

The cost of drotaverine is highly dependent on numerous factors such as organisation, manufacturers, quantity, and market. However, a cursory search online reveals that 10 40 mg generic drotaverine tablets are priced wholesale at approximately USD 0.34 by the pharmaceutical products company Walter Bushnell. Other forms of drotaverine such as vials or ampoules will be priced differently, as such, these values are only approximations for the current market situation. Although the prices on the B2B wholesale Pipelinepharma marketplace remain confidential between both B2B parties, the seller may choose to list a desired price to facilitate the online transaction. If so, an ‘Accept’ and ‘Negotiate’ button will be displayed through the online interface, with a ‘Get offer’ button being shown in the absence.